grant

RNAi therapeutic intervention of human viral respiratory disease [ 2008 - 2012 ]

Also known as: Novel strategies to treat viral respiratory disease

Funded by National Health and Medical Research Council
Managed by Griffith University
Provided by   National Health and Medical Research Council

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/508601]

Researchers: Prof Suresh Mahalingam (Principal investigator) ,  A/Pr Kirsten Spann ,  Prof Ralph Tripp

Brief description Human metapneumovirus (HMPV), causes clinical disease that is very similar to human respiratory syncytial virus (RSV) and co-circulates with RSV. HMPV is emerging as a major cause of morbidity and life-threatening respiratory tract disease in infants, young children and the elderly worldwide. No treatment is currently available. The objectives of this proposal are to develop novel antiviral drugs that silence the expression of viral genes and to examine protection against the disease.

Funding Amount $AUD 584,117.62

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Help

Related Organisations

Related People

Subjects
321027 | Acute laryngotracheitis | Airway hyperresponsiveness | Antivirals | Asthma | Bronchiolitis | Human Metapneumovirus | Inflammation | Lower respiratory tract infection | Respiratory Syncytial virus | Upper respiratory tract infection |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA